Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

OmniAb, Inc. (OABI) Profit Margins

Over the twelve months to 2026-06-30, OmniAb, Inc. (OABI) had operating margin -125.8%, net margin -115.1%, free cash flow margin -47.2%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OABIOmniAb, Inc.Follow OABI — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
677.5M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
30 Oct, in 6 days
LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin———98.4%—
Operating margin-45.1%-203.2%-282.3%-369.5%-125.8%
Net margin-37.8%-148.2%-235.1%-347.0%-115.1%
FCF margin-35.1%2.1%-157.4%-198.3%-47.2%

USD millions · SEC XBRL

OmniAb, Inc. — questions

What is OmniAb, Inc.'s operating margin?
-125.8% over the twelve months to 2026-06-30.
What is OmniAb, Inc.'s net profit margin?
-115.1% over the twelve months to 2026-06-30.

Every figure on this page comes from OmniAb, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.